File(s) not publicly available

Pharmaceutical patent protection and TRIPS challenges for Bangladesh : an appraisal of Bangladesh's Patent Office and Department of Drug Administration

journal contribution
posted on 06.12.2017, 00:00 by Mohammad Azam, Kristy Richardson
This paper examines the TRIPS Agreement as it applies to Bangladesh in the context of pharmaceutical patents. An important aspect of the Agreement is ensuring that the regulatory agencies are ready and able to apply and interpret the new intellectual property regime that will be required by TRIPS. An appraisal of the capacity of Bangladesh's regulatory agencies, particularly the Department of Patent Design and Trademarks and the Directorate of Drug Administration becomes even more important as Bangladesh is required to have a TRIPS compliant regime for the pharmaceutical sector from 1 January 2016.

Funding

Category 1 - Australian Competitive Grants (this includes ARC, NHMRC)

History

Volume

22

Issue

2

Start Page

1

End Page

15

Number of Pages

15

ISSN

1033-4505

Location

Gold Coast, Queensland

Publisher

Bond University

Language

en-aus

Peer Reviewed

Yes

Open Access

No

External Author Affiliations

Faculty of Arts, Business, Informatics and Education;

Era Eligible

Yes

Journal

Bond law review.